Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for the Prevention of Postpericardiotomy Syndrome (COPPS)
NCT00128427Phase 3Completed
- Sponsor
- ASL TO3
- Start
- Jun 2005
- Primary completion
- Jun 2010
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of colchicine in postpericardiotomy syndrome (PPS), sponsored by ASL TO3. Primary endpoint: Postpericardiotomy syndrome at 12 months. Started Jun 2005; status: completed.
02
Drugs
colchicine
03
Conditions
postpericardiotomy syndrome (PPS)
Beyond the preview
Go deeper on NCT00128427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128427.